Jiangsu GDK Biotechnology Co Ltd (688670) — Cash Flow Reinvestment Rate
Jiangsu GDK Biotechnology Co Ltd (688670) has a Cash Flow Reinvestment Rate of 17.95x as of December 2023, reinvesting CN¥407.60 Million (capex CN¥35.83 Million plus investments CN¥-371.77 Million) from operating cash flow of CN¥22.70 Million. See 688670 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangsu GDK Biotechnology Co Ltd Cash Flow Reinvestment Rate (2020–2023)
Historical reinvestment intensity for Jiangsu GDK Biotechnology Co Ltd across 4 annual periods. For the full cash flow conversion analysis, see Jiangsu GDK Biotechnology Co Ltd operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Jiangsu GDK Biotechnology Co Ltd (2020–2023)
Year-by-year capital reinvestment analysis for Jiangsu GDK Biotechnology Co Ltd. See Jiangsu GDK Biotechnology Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.81x | CN¥65.30 Million | CN¥80.90 Million | CN¥54.00 Million | ▼ -88.9% |
| 2022 | 7.28x | CN¥280.87 Million | CN¥38.60 Million | CN¥168.18 Million | ▼ -45.3% |
| 2021 | 13.31x | CN¥1.38 Billion | CN¥103.93 Million | CN¥386.39 Million | ▲ +1199.5% |
| 2020 | 1.02x | CN¥112.07 Million | CN¥109.46 Million | CN¥40.81 Million | — |